Interview: Imaging in prognostic radiology in cancer. (February 2013)

• Record Type: Journal Article
• Authors: Mason, Ralph
• Is Part Of: Imaging in medicine. Volume 5:Number 1(2013)
• Page Start: 15
• Page End: 18
• Publication Date: 2013-02
• Subjects: Diagnostic imaging -- Periodicals; 616.075405
• DOI: 10.2217/iim.13.4
• Languages: English
• ISSNs: 1755-5205

Abstract

Ralph Mason speaks to Sarah Miller, Commissioning Editor. Dr Ralph Mason, an expert in prognostic radiology, currently serves as Director of the Cancer Imaging Program at UT Southwestern (TX, USA), putting his experience of over 20 years in cancer imaging, therapy and tumor pathophysiology to good use. He is also a Professor of radiology and a member of the Simmons Comprehensive Cancer Center. For many years, the work of Dr Mason and his colleagues has been supported by the National Cancer Institute, Cancer Prevention and Research Institute of Texas, Department of Defense breast and prostate cancer initiatives and various foundations. His primary research interest is prognostic radiology and his current work focuses on oxygen-sensitive MRI in various human cancers. In addition, Dr Mason is an expert in the development of novel 19 F NMR reporter strategies. His ongoing projects concern the investigation of novel gene reporter molecules, novel vascular disrupting agents and novel drug efficacy and approaches for the assessment of pathophysiology of tumor response to therapy.